GeneDx Holdings WGS Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Business | ||||||
| GeneDx | $437.47M+3.4% | $423.09M+6.1% | $398.88M+10.6% | $360.81M+10.0% | $327.95M+8.5% | |
| Total Revenue by Product | ||||||
| Institutional customers | $68.29M-2.2% | $69.8M+2.4% | $68.19M+0.7% | $67.73M+2.6% | $66.05M+1.4% | |
| Patients with third-party insurance | $362.1M+4.9% | $345.24M+6.7% | $323.45M+12.3% | $287.97M+11.2% | $258.92M+10.3% | |
| Self-pay patients | $1.55M+14.0% | $1.36M-18.2% | $1.66M+11.3% | $1.5M-19.1% | $1.85M-21.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does GeneDx Holdings break its business down?
- GeneDx Holdings (WGS) reports total revenue by business across 2 parts — GeneDx and Other. Each is extracted from the segment footnotes and tracked over time.
- Where does GeneDx Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in GeneDx Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.